Drinking tea provides a number of health benefits, from lowering heart disease and stroke risk, to protecting against several types of cancer. The less processed tea leaves are, the more health-promoting compounds they contain.
Colonoscopy is the most effective way to prevent colon cancer, but it is more inconvenient and carries more risks than other options.
A study done at a large hospital found that the lifetime risk of painful complications from diverticulosis may be lower than experts thought.
There is no good proof that dietary supplements are helpful for enhancing memory. A healthy lifestyle is associated with brain fitness.
Atrial fibrillation is a fast irregular rhythm in the heart’s upper chambers. It is a major risk factor for stroke. A host of new devices and technologies offer promise to people with atrial fibrillation who are not helped by medications.
Angioplasty and stent placement, which widens a narrowed coronary artery, quickly restores blood flow during a heart attack or unstable angina.
A Mediterranean diet rich in extra-virgin olive oil cuts the chance of developing diabetes by almost a third.
A pharmacological stress test is a good alternative to a standard exercise stress test when a condition makes exercise difficult. Both can help detect heart problems, but the exercise test can also help a doctor determine a safe level of exercise.
The symptoms of a transient ischemic attack (TIA) often go away on their own, but they are a warning that a person is at greatly increased risk for a true stroke.
U.S. drug regulators are considering whether to dial back warnings about increased heart-attack risk for the pain reliever naproxen. But an advisory panel voted this week against the idea. Naproxen (Naprosyn, Aleve and others) is a nonsteroidal anti-inflammatory drug (NSAID). Others in this group include aspirin, ibuprofen (Motrin, Advil and others) and the prescription drug celecoxib (Celebrex). They relieve pain and inflammation and reduce fevers. But in the last 10 years evidence has built up that these drugs also may increase the risk of heart attack. The drug labels carry warnings about this risk. But a research analysis published last year suggested there was a lower risk of heart problems with naproxen than with other NSAIDs. So the Food and Drug Administration (FDA) said it would consider a label change for naproxen.